Quince Therapeutics Settles Approximately $16.4 Million of Debt

Core Insights - Quince Therapeutics, Inc. has successfully settled its outstanding obligations under a loan from the European Investment Bank for a payment of $5.5 million, marking a significant milestone for the company [1] Financial Summary - The settlement of the $5.5 million loan resolves critical debt obligations for Quince Therapeutics, enabling the company to advance its restructuring efforts [1] - This financial move is aimed at evaluating strategic alternatives to maximize shareholder value [1]